Key result
Regular use of proton-pump inhibitors was associated with a 16% higher risk of incident stroke compared to non-users.
Why the study?
Randomized controlled trials suggested a non-significant increased risk of stroke among PPI users, but the association remained unconfirmed.
Does regular use of proton-pump inhibitors increase the risk of incident stroke in adults?
Cohort (n=492,479)
Yes
Does regular use of proton-pump inhibitors increase the risk of incident stroke in adults?
Regular use of proton-pump inhibitors is associated with a modestly increased risk of incident stroke, with the absolute risk being highest among individuals with a high baseline stroke risk.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for PPI-associated stroke risk; should not alter prescribing pending randomized confirmation.
BACKGROUND: Although randomized controlled trials (RCTs) have suggested a non-significant increased risk of stroke among proton pump inhibitor (PPI) users, the association has not been confirmed. We evaluated the association between regular use of PPIs and incident stroke and identified population groups at high net risk. METHODS: This is a prospective analysis of 492,479 participants free of stroke from the UK biobank. Incident stroke was identified through linkage to hospital admission and death registries using the International Classification of Diseases (ICD)-10 codes (I60, I61, I63, and I64). We evaluated hazard ratios (HRs) adjusting for demographic factors, lifestyle habits, prevalent comorbidities, concomitant use of medications, and indications of PPIs. We assessed the risk differences (RDs) according to the baseline Framingham Stroke Risk Score. In the meta-analysis, we searched PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials (from 1988 to 1 June 2020) for randomized trials comparing PPIs with other interventions, placebo, or no treatment on stroke risk. Results were combined using a fix-effect meta-analysis (Mantel-Haenszel method). RESULTS: We documented 5182 incident strokes over 3,935,030 person-years of follow-up. Regular PPI users had a 16% higher risk of stroke than non-users (HR 1.16, 95% CI 1.06 to 1.27). The estimated effect was similar to our meta-analysis of nine RCTs (case/participants 371/26,642; RR 1.22, 95% CI 1.00 to 1.50; quality of evidence: moderate). The absolute effect of PPI use on stroke increased with the baseline Framingham Stroke Risk Score, with an RD of 1.34‰, 3.32‰, 4.83‰, and 6.28‰ over 5 years for the lowest, quartile 2, quartile 3, and the highest quartile, respectively. CONCLUSIONS: Regular use of PPIs was associated with an increased risk of stroke, with a higher absolute risk observed in individuals with high baseline stroke risk. Physicians should therefore exercise caution when prescribing PPIs. An assessment of the underlying stoke risk is recommended for individualized use of PPIs.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2021) conducted a cohort in General population free of stroke (n=492,479). Proton-pump inhibitors vs. Non-users was evaluated on Incident stroke (HR 1.16, 95% CI 1.06-1.27). Regular use of proton-pump inhibitors was associated with a 16% higher risk of incident stroke compared to non-users.
Synapse has enriched 10 related papers. Consider them for comparative context: